Technology in Cancer Research & Treatment,
Journal Year:
2023,
Volume and Issue:
22
Published: Jan. 1, 2023
Colorectal
adenoma
is
a
precancerous
lesion
that
may
progress
to
colorectal
cancer.
Patients
with
had
4-fold
higher
risk
of
developing
malignancy
than
the
rest
population,
approximately
80%
cancer
originating
from
adenoma.
Therefore,
preventing
occurrence
and
progression
crucial
in
reducing
for
The
human
intestinal
microecology
complex
system
consisting
numerous
microbial
communities
sophisticated
structure.
Interactions
among
microorganisms
play
roles
maintaining
normal
structure,
digestion,
absorption,
metabolism,
other
functions.
largest
bank
or
fermentation
body.
Studies
suggest
microecological
imbalance,
one
most
important
environmental
factors,
an
essential
role
development
Based
on
complexity
studying
gut
microbiota
ecosystem,
its
specific
yet
be
elucidated.
In
addition,
further
studies
are
expected
provide
new
insights
regarding
prevention
treatment
This
article
reviews
relationship
mechanism
diversity
microbiota,
relevant
inflammatory
response,
immune
regulation,
metabolic
changes
presence
adenomas.
Cells,
Journal Year:
2022,
Volume and Issue:
12(1), P. 138 - 138
Published: Dec. 29, 2022
Colorectal
cancer
(CRC)
is
one
of
the
most
frequent
tumor
entities
worldwide
with
only
limited
therapeutic
options.
CRC
not
a
genetic
disease
several
mutations
in
specific
oncogenes
and/or
suppressor
genes
such
as
APC,
KRAS,
PIC3CA,
BRAF,
SMAD4
or
TP53
but
also
multifactorial
including
environmental
factors.
Cancer
cells
communicate
their
environment
mostly
via
soluble
factors
cytokines,
chemokines
growth
to
generate
favorable
microenvironment
(TME).
The
TME,
heterogeneous
population
differentiated
and
progenitor
cells,
plays
critical
role
regulating
development,
growth,
invasion,
metastasis
therapy
resistance.
In
this
context,
cytokines
from
TME
influence
each
other,
eliciting
an
inflammatory
milieu
that
can
either
enhance
suppress
metastasis.
Additionally,
lines
evidence
exist
composition
microbiota
regulates
processes,
controlled
by
cytokine
secretion,
play
carcinogenesis
progression.
review,
we
discuss
networks
between
microbiome
colorectal
related
treatment
strategies,
goal
cytokine-mediated
strategies
could
overcome
common
resistance
tumors.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Nov. 14, 2023
Tumor-associated
macrophages
(TAMs)
are
integral
to
the
tumor
microenvironment
(TME),
influencing
cancer
progression
significantly.
Attracted
by
cell
signals,
TAMs
exhibit
unparalleled
adaptability,
aligning
with
dynamic
milieu.
Their
roles
span
from
promoting
growth
and
angiogenesis
modulating
metastasis.
While
substantial
research
has
explored
fundamentals
of
TAMs,
comprehending
their
adaptive
behavior,
leveraging
it
for
novel
treatments
remains
challenging.
This
review
delves
into
TAM
polarization,
metabolic
shifts,
complex
orchestration
cytokines
chemokines
determining
functions.
We
highlight
complexities
TAM-targeted
focusing
on
adaptability
potential
variability
in
therapeutic
outcomes.
Moreover,
we
discuss
synergy
integrating
TAM-focused
strategies
established
treatments,
such
as
chemotherapy,
immunotherapy.
Emphasis
is
laid
pioneering
methods
like
reprogramming
immunotherapy
adoption
single-cell
technologies
precision
intervention.
synthesis
seeks
shed
light
TAMs’
multifaceted
cancer,
pinpointing
prospective
pathways
transformative
enhancing
modalities
oncology.
Molecules,
Journal Year:
2023,
Volume and Issue:
28(13), P. 5081 - 5081
Published: June 29, 2023
Chemoprevention
is
one
of
the
ways
to
fight
colorectal
cancer,
which
a
huge
challenge
in
oncology.
Numerous
pieces
evidence
indicate
that
chronic
inflammation
course
Crohn’s
disease
or
ulcerative
colitis
(UC)
significant
cancer
risk
factor.
Epidemiologic
studies
suggest
long-term
use
non-steroidal
anti-inflammatory
drugs
(NSAIDs),
including
mesalazine,
has
beneficial
effects
on
colitis-associated
cancer.
Mesalazine
first-line
therapy
for
UC
and
also
widely
used
maintaining
remission
UC.
Data
showed
mesalazine
antiproliferative
properties
associated
with
cyclooxygenase
(COX)
inhibition
but
can
act
through
COX-independent
pathways.
This
review
summarizes
knowledge
about
mesalazine’s
molecular
mechanisms
action
chemopreventive
effect
by
it
could
interfere
cell
proliferation
survival.
Thrombosis Journal,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Aug. 9, 2023
Lavender
oil
(LO)
possesses
anti-inflammatory,
antioxidant,
antifungal,
antibacterial,
sedative,
cardio-protective,
and
antinociceptive
properties.
Thrombosis
inflammation
are
interplayed
processes
that
interact
influence
one
another.
Our
research
compared
three
routes
of
administration
to
assess
the
efficacy
pretreatment
with
LO
on
carrageenan-induced
thrombosis
in
rat
tail.Wistar-Bratislava
white
rats
were
randomly
divided
into
five
groups
ten
each
pretreated
3
consecutive
days
prior
inducement
dose
(150
mg/kg
body
weight
(b.w.)):
per
os
by
gavage
(TLOPO
group),
intraperitoneal
(TIPLO
group)
subcutaneous
(TSCLO
group).
We
also
have
a
control
(C,
received
saline
solution
0.9%
DMSO
(vehicle)
1
ml
(i.p.))
group
(T
group,
plus
vehicle
i.p.).
Histopathological
examinations
conducted
together
measurements
circulating
levels
oxidative
stress
markers,
antioxidant
effect
(TAC
THIOL),
proinflammatory
cytokines
(TNF-
α,
RANTES,
MCP-1).When
administered
intraperitoneally,
lavender
has
best
parameters
(MDA,
NOx,
TOS),
marker
(THIOL),
all
studied
(p-values
<
0.02).
Moreover,
TIPLO
displayed
closest
values
for
bleeding
clotting
time
C
as
well
lowest
length
thrombus
than
T,
TPOLO,
TSCLO
0.001).
The
histological
appearance
comparable
exception
presence
oedema.Lavender
days,
one-dose
day,
showed
anti-inflammatory
experimentally
induced
thrombosis.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: June 24, 2024
Background
Colorectal
cancer
(CRC)
is
a
significant
health
issue,
with
notable
incidence
rates
in
Norway.
The
immune
response
plays
dual
role
CRC,
offering
both
protective
effects
and
promoting
tumor
growth.
This
research
aims
to
provide
detailed
screening
of
immune-related
genes
identify
specific
CRC
adenomatous
polyps
within
the
Norwegian
population,
potentially
serving
as
detection
biomarkers.
Methods
study
involved
69
patients
(228
biopsies)
undergoing
colonoscopy,
divided
into
polyps,
control
groups.
We
examined
expression
579
through
nCounter
analysis
emphasizing
differential
versus
adjacent
non-tumorous
tissue
performed
quantitative
reverse
transcription
polymerase
chain
reaction
(RT-qPCR)
across
patient
categories.
Results
Key
findings
include
elevated
CXCL1,
CXCL2,
IL1B,
IL6,
CXCL8
(IL8),
PTGS2,
SPP1
tissues.
Additionally,
CXCL8,
PTGS2
showed
changes
suggesting
their
early
involvement
carcinogenesis.
Conclusions
uncovers
distinctive
immunological
signature
colorectal
neoplasia
among
Norwegians,
highlighting
potential
These
warrant
further
confirm
explore
utility
non-invasive
strategies.
Animal Models and Experimental Medicine,
Journal Year:
2024,
Volume and Issue:
7(5), P. 591 - 605
Published: Aug. 13, 2024
Flavonoids,
including
fisetin,
have
been
linked
to
a
reduced
risk
of
colorectal
cancer
(CRC)
and
potential
therapeutic
applications
for
the
condition.
Fisetin,
natural
flavonoid
found
in
various
fruits
vegetables,
has
shown
promise
managing
CRC
due
its
diverse
biological
activities.
It
influence
key
cell
signaling
pathways
related
inflammation,
angiogenesis,
apoptosis,
transcription
factors.
The
results
this
study
demonstrate
that
fisetin
induces
colon
apoptosis
through
multiple
mechanisms.
impacts
p53
pathway,
leading
increased
levels
decreased
murine
double
minute
2,
contributing
induction.
Fisetin
also
triggers
release
important
components
apoptotic
process,
such
as
second
mitochondria-derived
activator
caspase/direct
inhibitor
apoptosis-binding
protein
with
low
pI
cytochrome
c.
Furthermore,
inhibits
cyclooxygenase-2
wingless-related
integration
site
(Wnt)/epidermal
growth
factor
receptor/nuclear
kappa
B
pathways,
reducing
Wnt
target
gene
expression
hindering
colony
formation.
achieves
by
regulating
activities
cyclin-dependent
kinase
2
4,
retinoblastoma
phosphorylation,
decreasing
cyclin
E
levels,
increasing
p21
ultimately
influencing
E2
promoter
binding
1
division
cycle
(CDC2)
levels.
Additionally,
exhibits
effects
on
cells,
inhibiting
phosphorylation
Y-box
ribosomal
S6
kinase,
promoting
extracellular
signal-regulated
1/2,
disrupting
repair
process
DNA
double-strand
breaks.
Moreover,
serves
an
adjunct
therapy
prevention
treatment
phosphatidylinositol-4,5-bisphosphate
3-kinase
catalytic
subunit
α
(PIK3CA)-mutant
CRC,
resulting
reduction
phosphatidylinositol-3
(PI3K)
expression,
Ak
strain
transforming
mTOR
activity,
downstream
proteins
cells
PIK3CA
mutation.
These
findings
highlight
multifaceted
position
it
promising
candidate
future
development.
World Journal of Stem Cells,
Journal Year:
2023,
Volume and Issue:
15(5), P. 281 - 301
Published: May 25, 2023
Colorectal
cancer
(CRC)
remains
the
third
most
prevalent
disease
and
involves
a
multi-step
process
in
which
intestinal
cells
acquire
malignant
characteristics.
It
is
well
established
that
appearance
of
distal
metastasis
CRC
patients
cause
poor
prognosis
treatment
failure.
Nevertheless,
last
decades,
aggressiveness
progression
have
been
attributed
to
specific
cell
population
called
stem
(CCSC)
with
features
like
tumor
initiation
capacity,
self-renewal
acquired
multidrug
resistance.
Emerging
data
highlight
concept
this
subtype
as
plastic
entity
has
dynamic
status
can
be
originated
from
different
types
through
genetic
epigenetic
changes.
These
alterations
are
modulated
by
complex
crosstalk
environmental
factors
paracrine
signaling.
known
niche,
types,
structures,
biomolecules
coexist
interact
favoring
growth
development.
Together,
these
components
constitute
microenvironment
(TME).
Most
recently,
researchers
also
deepened
influence
variety
microorganisms
inhabit
mucosa,
collectively
gut
microbiota,
on
CRC.
Both
TME
participate
inflammatory
processes
drive
evolution
Since
decade,
crucial
advances
made
concerning
synergistic
interaction
among
condition
identity
CCSC,
exposed
review
could
provide
valuable
insights
into
biology
development
new
targeted
therapies.
SANAMED,
Journal Year:
2025,
Volume and Issue:
00, P. 76 - 76
Published: Jan. 1, 2025
Colorectal
cancer
is
one
of
the
most
common
malignant
tumors,
with
numerous
studies
highlighting
role
inflammation
in
its
onset
and
progression.
Cytokines
such
as
IL-6
TNF-a
play
a
crucial
sustaining
inflammation,
contributing
to
transformation
cells.
The
dietary
inflammatory
index,
which
reflects
intake
pro-inflammatory
nutrients,
associated
an
increased
risk
developing
colorectal
cancer.
Serum
cytokine
concentrations
may
serve
biomarkers
for
assessment,
while
modifications
aimed
at
reducing
can
significantly
impact
both
prevention
therapy.
This
knowledge
opens
possibilities
personalized
approach
treatment